| Dr Lois E Nielsen, MD | |
|
120 Sister Pierre Dr, Suite # 206, Towson, MD 21204-7516 | |
| (410) 296-3650 | |
| (410) 296-3641 |
| Full Name | Dr Lois E Nielsen |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Location | 120 Sister Pierre Dr, Towson, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073539839 | NPI | - | NPPES |
| KF68/ 403096-01 | Other | MD | BC/BS OF MD |
| S190 / 0002 | Other | MD | BLUE CHOICE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | D0038327 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lois E Nielsen, MD Po Box 62026, Baltimore, MD 21264-2026 Ph: () - | Dr Lois E Nielsen, MD 120 Sister Pierre Dr, Suite # 206, Towson, MD 21204-7516 Ph: (410) 296-3650 |
News Archive
Researchers from Davos Life Science in Singapore, in collaboration with scientists at the University of Hong Kong, have shown that gamma-tocotrienol, a member of the vitamin E family, is potent in killing prostate tumour cells in animal model studies. This research was reported this week in the latest edition of Pharmacology.
Tobacco companies may be using web 2.0 media, such as YouTube, to market their products to young people, so getting round marketing restrictions for tobacco content in place elsewhere, suggests research published online in Tobacco Control.
Depomed, Inc. announced today that it has received a second $500,000 milestone payment under its worldwide license agreement with Covidien focusing on the exclusive development of four acetaminophen/opioid analgesic combination products utilizing Depomed's Acuform® gastric retentive drug delivery technology. The most recent payment from Covidien, which was received in December 2009, relates to the development of a formulation for the second product candidate under the collaboration.
Three products for patients with end stage renal disease (ESRD) have been chosen to participate in the FDA's Innovation Pathway, an evolving system designed to help medical devices reach patients in a safe, timely and collaborative manner.
Hematopoietic stem cells, that form mature blood cells, require a very precise amount of protein to function - and defective regulation of protein production is common in certain types of aggressive human blood cancers.
› Verified 9 days ago
James Charles Kleeman Jr., MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 7505 Osler Dr, Suite 308, Towson, MD 21204 Phone: 410-296-1464 Fax: 410-296-1480 | |
Dr. David S. Berliner, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 515 Fairmount Ave, Ste 400, Towson, MD 21286 Phone: 410-494-1397 Fax: 410-584-2247 | |
Dr. Alice S Hsieh, D.O. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1000 E Joppa Rd, Suite 313, Towson, MD 21286 Phone: 410-825-5216 | |
John Loome, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 515 Fairmount Ave, 9th Floor, Towson, MD 21286 Phone: 410-494-7671 | |
Vikas Kalra, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7505 Osler Dr Ste 103, Towson, MD 21204 Phone: 410-427-2580 | |
Anum Qureshi, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 6565 N Charles St, Towson, MD 21204 Phone: 443-849-3760 Fax: 443-849-8138 | |
Ashraf S Mostafa, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7505 Osler Drive, Suite 208, Towson, MD 21204 Phone: 410-821-7572 Fax: 410-321-9831 |